Phase 2B Study to Evaluate the Efficacy of Bentracimab (PB2452) in Reversal of Ticagrelor in Subjects Aged 50-80 Years Old

NCT04122170 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Ticagrelor Oral Tablet - Pre-Treatment
DRUG: Aspirin (ASA) Oral Tablet - Pre-Treatment
DRUG: Bentracimab (PB2452) Infusion
DRUG: Placebo (0.9% Sodium chloride) infusion

Sponsor

SFJ Pharmaceuticals, Inc.